ESSA Pharma Inc. (EPIX): Price and Financial Metrics
EPIX Price/Volume Stats
| Current price | $1.71 | 52-week high | $7.88 |
| Prev. close | $1.71 | 52-week low | $1.40 |
| Day low | $1.69 | Volume | 75,414 |
| Day high | $1.73 | Avg. volume | 184,350 |
| 50-day MA | $1.67 | Dividend yield | N/A |
| 200-day MA | $2.79 | Market Cap | 75.91M |
EPIX Stock Price Chart Interactive Chart >
ESSA Pharma Inc. (EPIX) Company Bio
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.
EPIX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EPIX Price Returns
| 1-mo | -1.16% |
| 3-mo | 4.27% |
| 6-mo | 0.59% |
| 1-year | -70.62% |
| 3-year | -66.54% |
| 5-year | -66.47% |
| YTD | -4.47% |
| 2024 | -72.88% |
| 2023 | 161.90% |
| 2022 | -82.25% |
| 2021 | 19.03% |
| 2020 | 116.91% |